|
[1]
|
Lu, J., Zhang, C., Lv, J., et al. (2021) Antiallergic Drug Desloratadine as a Selective Antagonist of 5HT2A Receptor Ameliorates Pathology of Alzheimer’s Disease Model Mice by Improving Microglial Dysfunction. Aging Cell, 20, e13286. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Srivastava, S., Ahmad, R. and Khare, S.K. (2021) Alzheimer’s Disease and Its Treatment by Different Approaches: A Review. European Journal of Medicinal Chemistry, 216, Article ID: 113320. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chu, L.W. (2012) Alzheimer’s Disease: Early Diagnosis and Treatment. Hong Kong Medical Journal, 18, 228-237.
|
|
[4]
|
Birks, J. (2006) Cholinesterase Inhibitors for Alzheimer’s Disease. The Cochrane Database of Systematic Reviews, No. 1, CD005593. [Google Scholar] [CrossRef]
|
|
[5]
|
Hansen, R.A., Gartlehner, G., Webb, A.P., et al. (2008) Effi-cacy and Safety of Donepezil, Galantamine, and Rivastigmine for the Treatment of Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Clinical Interventions in Aging, 3, 211-225.
|
|
[6]
|
Qaseem, A., Snow, V., Cross, J.T., et al. (2008) Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians. Annals of Internal Medicine, 148, 370-378. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Stazi, M. and Wirths, O. (2021) Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alz-heimer’s Disease. Molecular Neurobiology, 58, 204-216. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Irshad, M. and Chaudhuri, P.S. (2002) Oxidant-Antioxidant System: Role and Significance in Human Body. Indian Journal of Experimental Biology, 40, 1233-1239.
|
|
[9]
|
Nair, S., Rocha-Ferreira, E., Fleiss, B., et al. (2021) Neuroprotection Offered by Mesenchymal Stem Cells in Perinatal brain Injury: Role of Mitochondria, Inflammation, and Reactive Oxygen Species. Journal of Neurochemistry, 158, 59-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Jiang, Q. (2014) Natural Forms of Vitamin E: Metabolism, Antioxidant and Anti-Inflammatory Activities and the Role in Disease Prevention and Therapy. Free Radical Biology & Medicine, 72, 76-90. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
La Fata, G., Weber, P. and Mohajeri, M.H. (2014) Ef-fects of Vitamin E on Cognitive Performance during Ageing and in Alzheimer’s Disease. Nutrients, 6, 5453-5472. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Mangialasche, F., Solomon, A., Kåreholt, I., et al. (2013) Serum Levels of Vitamin E Forms and Risk of Cognitive Impairment in a Finnish Cohort of Older Adults. Experimental Gerontology, 48, 1428-1435. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Luchsinger, J.A., et al. (2003) Antioxidant Vitamin Intake and Risk of Alzheimer Disease. Archives of Neurology, 60, 203-208.
https://jamanetwork.com/journals/jamaneurology/fullarticle/783735
|
|
[14]
|
Lloret, A., Badía, M.-C., Mora, N.J., et al. (2009) Vitamin E Paradox in Alzheimer’s Disease: It Does Not Prevent Loss of Cognition and May Even Be Detrimental. Journal of Alzheimer’s Disease, 17, 143-149. [Google Scholar] [CrossRef]
|
|
[15]
|
Singh, S.K., Srivastav, S., Castellani, R.J., et al. (2019) Neuroprotective and Antioxidant Effect of Ginkgo Biloba Extract against AD and Other Neurological Disorders. Neurotherapeutics, 16, 666-674. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Verma, S., Ranawat, P., Sharma, N., et al. (2019) Ginkgo Biloba Attenuates Aluminum Lactate-Induced Neurotoxicity in Reproductive Senescent Female Rats: Behavioral, Biochemical, and Histopathological Study. Environmental Science and Pollution Research, 26, 27148-27167. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Mazza, M., Capuano, A., Bria, P., et al. (2006) Ginkgo Biloba and Donepezil: A Comparison in the Treatment of Alzheimer’s Dementia in a Randomized Placebo-Controlled Dou-ble-Blind Study. European Journal of Neurology, 13, 981-985. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Canevelli, M., Adali, N., Kelaiditi, E., et al. (2014) Effects of Gingko Biloba Supplementation in Alzheimer’s Disease Patients Receiving Cholinesterase Inhibitors: Data from the ICTUS Study. Phytomedicine, 21, 888-892. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Wilkins, T.L. and Sambamoorthi, U. (2011) Antidepressant Use, Depression, Lifestyle Factors, and New-Onset Diabetes. International Clinical Psychopharmacology, 26, 159-168. [Google Scholar] [CrossRef]
|
|
[20]
|
Carson, S., McDonagh, M.S. and Peterson, K. (2006) A Systematic Review of the Efficacy and Safety of Atypical Antipsychotics in Patients with Psychological and Behavioral Symptoms of Dementia. Journal of the American Geriatrics Society, 54, 354-361. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Schneider, L.S., Dagerman, K.S. and Insel, P. (2005) Risk of Death with Atypical Antipsychotic Drug Treatment for Dementia: Meta-Analysis of Randomized Placebo-Controlled Trials. JAMA, 294, 1934-1943. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Phiri, P., Engelthaler, T., Carr, H., et al. (2022) Associated Mortality Risk of Atypical Antipsychotic Medication in Individuals with Dementia. World Journal of Psychiatry, 12, 298. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Chan, T.-C., Luk, J.K.-H., Shea, Y.-F., et al. (2011) Continuous Use of Antipsychotics and Its Association with Mortality and Hospitalization in Institutionalized Chinese Older Adults: An 18-Month Prospective Cohort Study. International Psychogeriatrics, 23, 1640-1648. [Google Scholar] [CrossRef]
|
|
[24]
|
Ji, W., Gong, B., Jin, H., et al. (2021) Recent Progress towards Vaccines and Antibody-Based Therapies against Alzheimer’s Disease. Mini Reviews in Medicinal Chemistry, 21, 3062-3072. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Decourt, B., Boumelhem, F., Pope, E.D., et al. (2021) Critical Appraisal of Amyloid Lowering Agents in AD. Current Neurology and Neuroscience Reports, 21, 39. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Bang, O.Y. and Kim, J.-E. (2022) Stem Cell-Derived Extracel-lular Vesicle Therapy for Acute Brain Insults and Neurodegenerative Diseases. BMB Reports, 55, 20-29. [Google Scholar] [CrossRef]
|
|
[27]
|
Acharya, M.M., Christie, L.-A., Lan, M.L., et al. (2009) Rescue of Radiation-Induced Cognitive Impairment through Cranial Transplantation of Human Embryonic Stem Cells. Proceedings of the National Academy of Sciences of the United States of America, 106, 19150-19155. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zhang, L., Zhao, P., Yue, C., et al. (2019) Sustained Release of Bioactive Hydrogen by Pd Hydride Nanoparticles Overcomes Alzheimer’s Disease. Biomaterials, 197, 393-404. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Cano, A., Turowski, P., Ettcheto, M., et al. (2021) Nanomedicine-Based Technologies and Novel Biomarkers for the Diagnosis and Treatment of Alzheimer’s Disease: From Current to Future Challenges. Journal of Nanobiotechnology, 19, 122. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Quail, Z., Carter, M.M., Wei, A., et al. (2020) Management of Cognitive Decline in Alzheimer’s Disease Using a Non-Pharmacological Intervention Program: A Case Report. Medicine, 99, e20128. [Google Scholar] [CrossRef]
|
|
[31]
|
Gold, K. (2014) But Does It Do Any Good? Measuring the Impact of Music Therapy on People with Advanced Dementia: (Innovative Practice). Dementia, 13, 258-264. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Pavlicevic, M., Tsiris, G., Wood, S., et al. (2015) The “Ripple Effect”: Towards Researching Improvisational Music Therapy in Dementia Care Homes. Dementia, 14, 659-679. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Popa, L.-C., Manea, M.C., Velcea, D., et al. (2021) Impact of Alzheimer’s Dementia on Caregivers and Quality Improvement through Art and Music Therapy. Healthcare, 9, 698. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Tung, B.T., Rodriguez-Bies, E., Thanh, H.N., et al. (2015) Organ and Tissue-Dependent Effect of Resveratrol and Exercise on Antioxidant Defenses of Old Mice. Aging Clinical and Experimental Research, 27, 775-783. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Sampaio, A., Marques-Aleixo, I., Seabra, A., et al. (2021) Phys-ical Exercise for Individuals with Dementia: Potential Benefits Perceived by Formal Caregivers. BMC Geriatrics, 21, 6. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Heyn, P.C., Johnsons, K.E. and Kramer, A.F. (2008) Endurance and Strength Training Outcomes on Cognitively Impaired and Cognitively Intact Older Adults: A Meta-Analysis. The Journal of Nutrition Health and Aging, 12, 401-409. [Google Scholar] [CrossRef]
|
|
[37]
|
Yin, W., Lv, G., Li, C., et al. (2021) Acupuncture Therapy for Alz-heimer’s Disease: The Effectiveness and Potential Mechanisms. The Anatomical Record, 304, 2397-2411. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Dempsey, L., Murphy, K., Cooney, A., et al. (2014) Reminiscence in De-mentia: A Concept Analysis. Dementia, 13, 176-192. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Mitchell, G. and Agnelli, J. (2015) Non-Pharmacological Approaches to Alleviate Distress in Dementia Care. Nursing Standard, 30, 38-44. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Deshmukh, S.R., Holmes, J. and Cardno, A. (2018) Art Therapy for People with Dementia. Cochrane Database of Systematic Reviews, 9, CD011073. [Google Scholar] [CrossRef]
|
|
[41]
|
Rentz, D.M., Locascio, J.J., Becker, J.A., et al. (2009) Cognition, Reserve and Amyloid Deposition in Normal Aging. Annals of Neurology, 67, 353-364. [Google Scholar] [CrossRef] [PubMed]
|